A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Maverick Capital LTD holds 9,419 shares of IART stock, worth $274,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,419
Previous 8,652 8.87%
Holding current value
$274,940
Previous $376,000 11.44%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $25,617 - $34,668
767 Added 8.87%
9,419 $333,000
Q4 2023

Feb 14, 2024

BUY
$34.21 - $44.59 $40,504 - $52,794
1,184 Added 15.85%
8,652 $376,000
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $99,300 - $120,763
-2,627 Reduced 26.02%
7,468 $285,000
Q2 2023

Aug 14, 2023

SELL
$37.95 - $58.98 $2,314 - $3,597
-61 Reduced 0.6%
10,095 $415,000
Q1 2023

May 15, 2023

BUY
$52.61 - $60.49 $211,965 - $243,714
4,029 Added 65.76%
10,156 $583,000
Q4 2022

Feb 14, 2023

BUY
$42.17 - $58.6 $258,375 - $359,042
6,127 New
6,127 $343,000
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $437,727 - $513,262
-7,007 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$64.97 - $76.19 $993,521 - $1.17 Million
-15,292 Reduced 68.58%
7,007 $480,000
Q2 2021

Aug 16, 2021

BUY
$66.79 - $76.63 $831,335 - $953,813
12,447 Added 126.34%
22,299 $1.52 Million
Q1 2021

May 17, 2021

SELL
$62.63 - $71.15 $203,798 - $231,522
-3,254 Reduced 24.83%
9,852 $681,000
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $337,211 - $518,158
-7,786 Reduced 37.27%
13,106 $851,000
Q3 2020

Nov 16, 2020

BUY
$43.33 - $51.72 $905,250 - $1.08 Million
20,892 New
20,892 $987,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.44B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.